Download PDFPDF

4CPS-233 PD-l1 expression and histological type as predictors of response in metastasic non-small-cell lung cancer (NSCLC) patients treated with pembrolizumab in first-line
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
Sign In to Email Alerts with your Email Address